Cardiac Amyloidosis: Accelerating Diagnosis and Treatment

What You Will Learn

  • Identify symptomology of cardiac amyloidosis including key clinical characteristics.
  • Select appropriate testing and recognize findings suggestive of amyloidosis including biomarkers and echo.
  • Review treatment options for patients diagnosed with cardiac amyloidosis  

Exciting Update:

Since the recordings of these activities, there have been exciting announcements, including an FDA announcement and recently released study data. Stay tuned for updates and new activities to be released soon as we review the information.

We are grateful to these distinguished faculty who contributed to this collection:

Faculty Chair:

Michelle M. Kittleson, MD, FACC

 

Faculty: 

Amrut Ambardekar, MD, FACC

Jan Griffin, MD, FACC

Richard Kar-Hang Cheng, MD, FACC

Educational Grant Support Provided By: Alnylam Pharmaceuticals Inc., BridgeBio Pharma Inc., and Pfizer

Page Launched: September 2022

Android App Download IOS App Download Powered By